Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?-Reference-Cited by-同舟云学术

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

Published:2001 Issue:7 Volume:16 Page:653-666
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int. J. Geriat. Psychiatry

Author:

Winblad Bengt,Brodaty Henry,Gauthier Serge,Morris John C,Orgogozo Jean-Marc,Rockwood Kenneth,Schneider Lon,Takeda Masatoshi,Tariot Pierre,Wilkinson David

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference79 articles.

1. A randomized controlled trial of prednisone in Alzheimer's disease

2. Instrumental Activities of Daily Living as a Screening Tool for Cognitive Impairment and Dementia in Elderly Community Dwellers

3. An Inventory for Measuring Depression

4. Effectiveness of rivastigmine in Alzheimer's disease

5. 1998. Alzheimer's Disease in the United Kingdom. Health Policy Unit, Imperial School of Medicine: London.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Efficacy and Clinical Relevance of Artificial Intelligence in Detecting Cognitive Decline;Cureus;2023-10-13

2. Clinical Efficacy in Individual Patients Treated with Lecanemab;The Journal Of Prevention of Alzheimer's Disease;2023

3. Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial;Neurophysiologie Clinique;2022-04

4. Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease;British Journal of Clinical Pharmacology;2022-01-26